Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' Neuren Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Neuren Pharmaceuticals Limited since January 2007.
– Provides intelligence on Neuren Pharmaceuticals Limited's M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Neuren Pharmaceuticals Limited and its subsidiaries since 2007. – Information about key financial and legal advisors for Neuren Pharmaceuticals Limited's financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes Neuren Pharmaceuticals Limited's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Neuren Pharmaceuticals Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Neuren Pharmaceuticals Limited’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition
This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive,...
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
The global laboratory filtration market exhibited strong growth during 2015-2020. Filtration is a basic separation technique that is used for removing solid particles from liquids or gaseous fluids. The primary components of a filter include a filter medium and a housing or holder that contains the sample, as well as...
The global Raman spectroscopy market is projected to reach USD 861 million by 2026 from an estimated USD 602 million in 2021, at a CAGR of 7.4% from 2021 to 2026. The Rise in adoption of Raman spectroscopy in clinical applications and advancement in utilization of Raman spectroscopic techniques for catalysts and catalytic reactions are among...
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
The Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report provides a detailed understanding and analysis of how, why and what terms companies enter preclinical stage partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization...
The primary objective of this report is to provide in-depth knowledge of the global pharmaceutical and biopharmaceutical contract manufacturing, research and packaging market.
The contract manufacturing segment is further analyzed by various dosage forms, over-the-counter (OTC) options and nutraceuticals,...
Report Scope: This report studies the global yeast derivative market with 2020 as a base year and provides estimates for each year of the forecast period of 2021 to 2026, with projections of compound annual growth rates (CAGR).The scope of this report covers markets for yeast derivatives that are used globally. The...
The global Micropump market is expected to reach US$ 5,172.86 million in 2028 from as estimated value of US$ 1,553.01 million in 2021. The market is likely to grow with a CAGR of 18.8% from 2021-2028. The growth of the market is due to increasing demand for micropumps in medical device industry, and improved accuracy compared to traditional...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.